Abstract |
Eighty-one immunoscintigraphy (IS) studies in 80 patients with gastrointestinal malignancies were re-evaluated retrospectively to analyze accuracy and clinical impact of the IS findings. Selection of patients was based upon complete diagnostic records and a clinical follow-up of at least 6 months. The 3 antibody preparations used (99m-Tc labelled complete anti-CEA antibodies (BW 431/26), 111-In labelled F(ab')2-fragments against CEA (BW 431/31), and a mixture of 131-I labelled F(ab')2-fragments against CEA and CA 19-9 ( IMACIS-1] yielded equal diagnostic sensitivities (65%, range 60-78%) except for liver metastases. These were preferably detected by the 131-I labelled compound. Best results were gained in local recurrencies of gastrointestinal cancer (12/15 true positive = 80%). Among these were 3 out of the 4 lesions which had been exclusively recognized by IS. Thus IS should be applied in patients with suggested local recurrencies and inconclusive outcome of routine diagnostic workup. A widespread and frequent use of IS (e.g. screening of metastases) cannot be advocated since diagnostic results were not convincing and the immunologic risks of IS (development of human anti-mouse antibodies) are still under discussion.
|
Authors | R Bares, J Fass, G Weiller, S Wolter, E Kleinhans, S Truong, U Büll, V Schumpelick |
Journal | Onkologie
(Onkologie)
Vol. 12 Suppl 1
Pg. 13-8
(Aug 1989)
ISSN: 0378-584X [Print] Switzerland |
Vernacular Title | Klinische Bedeutung der Immunszintigraphie für Diagnose und Therapie gastrointestinaler Malignome. |
PMID | 2685690
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Antibodies, Monoclonal
- Antibody Specificity
- Gastrointestinal Neoplasms
(diagnostic imaging, surgery)
- Humans
- Liver Neoplasms
(diagnostic imaging, secondary)
- Neoplasm Recurrence, Local
(diagnostic imaging)
- Prognosis
- Retrospective Studies
- Tomography, Emission-Computed, Single-Photon
|